Results 221 to 230 of about 91,521 (343)

First Real‐World Evidence of an AI‐Enhanced Digital Collaborative Care Model to Improve IBS Symptoms

open access: yesNeurogastroenterology &Motility, EarlyView.
Participants engaged in the DCCM platform (Ayble Health) and self‐selected a care pathway. Seventy‐five percent of participants who engaged with a novel DCCM using a combination of brain–gut behavior therapy, dietary modification, and/or clinical care teams, enhanced by AI, experienced clinically significant symptom relief sustained up to 42 weeks ...
Stephen E. Lupe   +10 more
wiley   +1 more source

Hypnotic Susceptibility

open access: bronze, 1966
Eugene E. Levitt
openalex   +1 more source

Smartphone Application With Health Coaching Facilitates Multi‐Symptom Improvement in IBS Patients: A Pilot Feasibility Trial

open access: yesNeurogastroenterology &Motility, EarlyView.
Benefits of a smartphone application and health coaching in IBS patients. ABSTRACT Background Irritable bowel syndrome (IBS), a disorder of the gut‐brain interaction, is associated with significant symptom burden and impaired psychosocial functioning.
Max Eisele   +6 more
wiley   +1 more source

Pharmacokinetic and Pharmacodynamic Modeling of Clonidine and Midazolam for Sedation in Pediatric Intensive Care

open access: yesPediatric Anesthesia, EarlyView.
ABSTRACT Background Clonidine and midazolam are routinely used in the pediatric intensive care unit for pain and sedation management, but target concentration and optimal dose are poorly defined for both drugs. The CloSed study is a multicenter, double‐blind, randomized, active‐controlled noninferiority trial with a 1:1 randomization between clonidine ...
Maddlie Bardol   +22 more
wiley   +1 more source

Analysis of sedative-hypnotic drug use trends in children and adolescents (2018-2023): a study based on outpatient prescription data from a general hospital. [PDF]

open access: yesFront Pharmacol
Qingyu Z   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy